GO:2001287 negative regulation of caveolin-mediated endocytosis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001287 describes any process that stops, prevents, or reduces the frequency, rate, or extent of caveolin-mediated endocytosis, a clathrin-independent internalization route.
• Caveolin-mediated endocytosis is a major entry pathway for pathogens, including mimivirus in macrophages and Helicobacter pylori outer membrane vesicles.
• Negative regulation of this pathway controls signaling receptor turnover, as shown for TGF-beta type I receptor degradation promoted by PICK1.
• The pathway is distinct from clathrin-dependent endocytosis, which mediates internalization of LRP6 by Disabled-2 and UT-A1 by Rab14.
• Studying negative regulators requires methods that separate caveolin-dependent from clathrin-dependent uptake, such as pharmacological inhibitors and genetic perturbation.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate negative regulators in relevant cell types.
Description
Caveolin-mediated endocytosis is a clathrin-independent internalization mechanism that depends on caveolin proteins and is exploited by diverse pathogens and signaling receptors. The Gene Ontology term GO:2001287, negative regulation of caveolin-mediated endocytosis, captures any process that stops, prevents, or reduces the frequency, rate, or extent of this internalization route. Understanding this negative regulation is important because it determines how cells control receptor surface levels, pathogen entry, and downstream signaling. Unlike clathrin-dependent endocytosis, which is used by LRP6 and UT-A1 under the control of Disabled-2 and Rab14 respectively, caveolin-mediated uptake has distinct regulatory inputs that are only beginning to be defined. Pathogens such as mimivirus and Helicobacter pylori outer membrane vesicles enter host cells through caveolin-dependent or related routes, making negative regulators potential host-directed therapeutic targets. This article summarizes the definition, mechanisms, key genes, disease links, and experimental methods for studying GO:2001287, based strictly on published literature.
negative regulation of caveolin-mediated endocytosis At A Glance
| GO ID | GO:2001287 |
|---|---|
| GO term | negative regulation of caveolin-mediated endocytosis |
| Ontology | biological_process |
| Synonym | negative regulation of caveolae-dependent endocytosis; negative regulation of caveolae-mediated endocytosis; negative regulation of caveolin-dependent endocytosis |
| Major function | Reduces the frequency, rate, or extent of caveolin-mediated endocytosis |
| Related process | Caveolin-mediated endocytosis (GO:0072583) |
| Contrasting process | Clathrin-dependent endocytosis |
| Pathogen examples | Mimivirus, Helicobacter pylori outer membrane vesicles |
| Signaling example | TGF-beta type I receptor degradation via PICK1 |
What Is GO:2001287?
GO:2001287 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of caveolin-mediated endocytosis. In practice, this includes molecular events that inhibit caveolae formation, block caveolin recruitment to the membrane, promote caveolin degradation, or otherwise reduce the internalization of cargo through caveolin-dependent pathways. It is synonymous with negative regulation of caveolae-dependent endocytosis, caveolae-mediated endocytosis, and caveolin-dependent endocytosis.
Why Is negative regulation of caveolin-mediated endocytosis Important in Cell Biology?
Negative regulation of caveolin-mediated endocytosis is important because it controls a major route by which cells internalize signaling receptors, pathogens, and extracellular cargo. Dysregulation of this process can alter receptor availability, change pathogen susceptibility, and influence downstream signaling outputs such as TGF-beta responses. Because caveolin-mediated uptake is distinct from clathrin-dependent endocytosis, identifying specific negative regulators is essential for dissecting cargo-specific trafficking and for designing host-directed interventions against pathogens that exploit caveolae.
• Controls surface levels of signaling receptors such as TGF-beta type I receptor through degradation pathways.
• Modulates host cell entry of pathogens including mimivirus and Helicobacter pylori outer membrane vesicles.
• Provides a point of distinction from clathrin-dependent endocytosis, which handles LRP6 and UT-A1.
• Influences inflammatory responses in intestinal epithelial cells, as suggested by studies of exosome-like nanoparticles in Caco-2 cells.
• Relevant to cancer biology because receptor trafficking affects oncogenic signaling.
• Relevant to infectious disease because blocking caveolin-mediated entry may reduce pathogen load.
• Helps interpret pharmacological inhibitor studies that target endocytic pathways.
• Guides CRISPR-based functional screens for trafficking regulators.
• Supports development of host-directed therapeutics that do not rely on pathogen-specific targets.
• Enables mechanistic studies of caveolin protein stability and membrane dynamics.
What Happens During negative regulation of caveolin-mediated endocytosis?
Recognition of caveolin-dependent cargo
In simple terms: The cell first needs to identify cargo that would normally enter through caveolae.
Caveolin-mediated endocytosis is a clathrin-independent route used by pathogens such as mimivirus in macrophages and by Helicobacter pylori outer membrane vesicles in host cells. Negative regulation begins with processes that reduce the recognition or recruitment of such cargo to caveolae. Because this pathway is distinct from clathrin-dependent uptake of LRP6 and UT-A1, negative regulators must act selectively on caveolin-dependent steps.
Inhibition of caveolae formation or stabilization
In simple terms: The cell can block the assembly of the caveolae structures needed for uptake.
Caveolae are membrane invaginations that require caveolin proteins. Negative regulation can occur by reducing caveolin availability at the plasma membrane or by preventing stabilization of caveolae. Studies of pathogen entry show that different cargoes use distinct endocytic mechanisms, so inhibition of caveolae formation can selectively reduce caveolin-mediated uptake without affecting clathrin-mediated routes.
Promotion of caveolin degradation or removal
In simple terms: The cell can remove caveolin proteins so that caveolae cannot form.
PICK1 promotes caveolin-dependent degradation of TGF-beta type I receptor, demonstrating that trafficking regulators can direct cargo and machinery to degradation pathways. Negative regulation of caveolin-mediated endocytosis may therefore involve enhanced turnover of caveolin or associated proteins, reducing the capacity for caveolar uptake. This mechanism links negative regulation to receptor downregulation and signaling attenuation.
Interference with downstream scission and internalization
In simple terms: Even if caveolae form, the cell can stop them from pinching off.
After cargo recruitment and caveolae assembly, scission and internalization steps can be targeted by negative regulators. Because clathrin-dependent endocytosis uses different machinery, as shown for LRP6 internalization by Disabled-2 and UT-A1 downregulation by Rab14, negative regulators of caveolin-mediated endocytosis are expected to act on caveolae-specific scission components. Pathogen studies provide evidence that entry routes can be mechanistically separated, supporting the existence of selective negative regulation.
Outcomes for signaling and cell physiology
In simple terms: Blocking caveolin-mediated uptake changes what the cell sees and how it responds.
Reduced caveolin-mediated endocytosis can increase surface retention of receptors or decrease uptake of extracellular cargo. In intestinal Caco-2 cells, exosome-like nanoparticles from ginger modulate inflammatory responses, indicating that endocytic trafficking influences epithelial signaling. Negative regulation of caveolin-mediated endocytosis therefore has consequences for receptor signaling, pathogen entry, and inflammatory outputs.
Key Genes Involved in GO:2001287 negative regulation of caveolin-mediated endocytosis
The following genes and proteins have been experimentally linked to caveolin-mediated endocytosis, its negative regulation, or closely related endocytic routes, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAV1 | Core caveolin protein required for caveolae formation | Central to caveolin-mediated endocytosis and its negative regulation |
| CAV2 | Caveolin family member stabilizing caveolae | Potential target for negative regulation of caveolar uptake |
| PICK1 | Promotes caveolin-dependent degradation of TGF-beta type I receptor | Direct evidence for caveolin-dependent trafficking regulation |
| TGFBR1 | TGF-beta type I receptor internalized via caveolin-dependent route | Cargo whose degradation is linked to caveolin-dependent trafficking |
| DAB2 | Inhibits Wnt/beta-catenin signaling by promoting LRP6 internalization through clathrin | Contrasts clathrin-dependent vs caveolin-dependent routes |
| LRP6 | Wnt co-receptor internalized via clathrin | Helps distinguish clathrin-dependent from caveolin-dependent uptake |
| RAB14 | Down-regulates UT-A1 via enhanced clathrin-dependent endocytosis | Example of clathrin-specific regulation |
| UT-A1 | Urea transporter regulated by Rab14-mediated endocytosis | Model cargo for clathrin-dependent internalization |
| EPS15 | Clathrin-mediated endocytosis component | Used to differentiate clathrin-independent routes |
| MHV-2 | Mouse hepatitis virus type 2 enters via clathrin-mediated pathway independent of Eps15 | Pathogen model for endocytic route specificity |
| H. pylori OMV proteins | Outer membrane vesicle cargo entering host cells | Size-dependent entry mechanisms inform caveolin-mediated uptake |
| Caco-2 cell factors | Intestinal epithelial endocytic and inflammatory responses | Model for nanoparticle uptake and inflammation |
| Mimivirus entry factors | Phagocytic uptake in macrophages | Contrasts phagocytosis with caveolin-mediated endocytosis |
| Ginger exosome-like nanoparticle cargo | Modulates inflammation in intestinal cells | Links endocytic trafficking to anti-inflammatory effects |
| Caveolae-associated kinases | Potential regulators of caveolin phosphorylation | Candidate negative regulators of caveolin-mediated endocytosis |
| Ubiquitin-proteasome components | Mediate degradation of trafficking receptors | Potential mechanism for caveolin degradation |
| Membrane lipid regulators | Control caveolae stability | Candidate modulators of caveolin-mediated uptake |
| Rab GTPases | Regulate endocytic vesicle trafficking | Family includes Rab14 with clathrin-specific roles |
How Is negative regulation of caveolin-mediated endocytosis Regulated?
Negative regulation of caveolin-mediated endocytosis is controlled at multiple levels. PICK1 promotes caveolin-dependent degradation of TGF-beta type I receptor, showing that degradation machinery can direct caveolin-dependent cargo fate. Clathrin-dependent endocytosis is regulated by distinct factors such as Disabled-2 for LRP6 and Rab14 for UT-A1, indicating that endocytic routes are separately controlled. Pathogen entry studies demonstrate that cargo size and type determine which endocytic mechanism is used, providing a layer of regulation at the level of cargo selection. Pharmacological and genetic dissection of endocytic pathways, including Eps15-independent clathrin-mediated entry, further supports the existence of route-specific regulatory inputs.
negative regulation of caveolin-mediated endocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PICK1 | TGF-beta signaling and receptor degradation | Knockout and overexpression in epithelial cells |
| TGFBR1 | TGF-beta-driven cancer and fibrosis | Point mutation of caveolin-dependent degradation motifs |
| CAV1 | Pathogen entry and caveolae-related disorders | Knockout in macrophages or epithelial cells |
| LRP6 | Wnt signaling in cancer | Clathrin-dependent internalization controls |
| UT-A1 | Urea transport and kidney physiology | Rab14-mediated endocytosis models |
Infectious disease and pathogen entry
Caveolin-mediated endocytosis is exploited by pathogens such as mimivirus in macrophages and Helicobacter pylori outer membrane vesicles in host cells. Negative regulation of this pathway could reduce pathogen internalization and limit infection. Because entry mechanisms are size- and cargo-dependent, therapeutic strategies must account for route specificity.
Cancer and receptor signaling
PICK1 promotes caveolin-dependent degradation of TGF-beta type I receptor, linking caveolin-mediated trafficking to TGF-beta signaling control. Dysregulation of such negative regulation could alter receptor availability and downstream oncogenic or tumor-suppressive outputs. Distinguishing caveolin-dependent from clathrin-dependent routes, such as LRP6 internalization by Disabled-2, is critical for interpreting signaling phenotypes.
Inflammation and intestinal epithelial biology
Ginger exosome-like nanoparticles modulate inflammatory responses in intestinal Caco-2 cells, indicating that endocytic uptake of extracellular vesicles influences epithelial inflammation. Negative regulation of caveolin-mediated endocytosis may therefore affect inflammatory signaling in the gut. This area requires further direct studies to establish causality.
From negative regulation of caveolin-mediated endocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate caveolin-mediated endocytosis? | CRISPR knockout in a caveolin-dependent cargo uptake assay |
| Which domain of gene X is required for negative regulation? | Point mutation or domain deletion knock-in |
| Does a disease-associated variant alter negative regulation? | Knock-in of the variant followed by uptake assays |
| Where does gene X localize during negative regulation? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of gene X reduce caveolin-mediated uptake? | Stable or transient overexpression |
| Is the effect specific to caveolin-mediated vs clathrin-mediated endocytosis? | Parallel uptake assays with pathway-specific inhibitors and cargoes |
How to Study the negative regulation of caveolin-mediated endocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent cargo uptake assay | Rate of caveolin-mediated internalization | Testing candidate negative regulators |
| Clathrin-dependent cargo uptake assay | Specificity against clathrin-mediated endocytosis | Comparing LRP6 or UT-A1 internalization |
| Pharmacological inhibitor panel | Pathway dependence of uptake | Distinguishing caveolin vs clathrin routes |
| Co-immunoprecipitation | Protein-protein interactions | Identifying caveolin-associated complexes |
| Pulse-chase degradation assay | Turnover of cargo or machinery | Testing PICK1-mediated degradation |
| CRISPR knockout uptake screen | Causal role of candidate genes | Functional genomics of negative regulation |
| Live-cell imaging | Dynamics of caveolae and cargo | Visualizing negative regulation in real time |
| Inflammatory cytokine assay | Downstream signaling output | Linking trafficking to inflammation in Caco-2 cells |
Uptake assays with pathway-specific cargoes
Measuring internalization of fluorescently labeled cargoes that preferentially use caveolin-mediated endocytosis allows direct assessment of negative regulation. Parallel assays with clathrin-dependent cargoes such as LRP6 or UT-A1 help confirm specificity. Pathogen-derived cargoes, including Helicobacter pylori outer membrane vesicles, can be used to test entry route dependence.
Pharmacological and genetic dissection of endocytic routes
Inhibitors and genetic perturbations that block clathrin-mediated endocytosis, such as Eps15-independent entry models, help isolate caveolin-dependent steps. Combining these tools with knockout of candidate negative regulators provides causal evidence. Mimivirus entry studies in macrophages illustrate how distinct uptake mechanisms can be separated experimentally.
Protein degradation and trafficking analysis
Because PICK1 promotes caveolin-dependent degradation of TGF-beta type I receptor, pulse-chase, ubiquitination, and proteasome inhibition experiments can reveal whether negative regulation acts through degradation. Co-immunoprecipitation and proximity labeling can identify interacting partners. These approaches link negative regulation to receptor turnover.
Inflammation and signaling readouts
In Caco-2 cells, exosome-like nanoparticles modulate inflammatory responses, providing a readout for endocytic trafficking effects. Combining uptake measurements with cytokine or reporter assays connects negative regulation to downstream biology. Such integrated approaches are needed to establish physiological relevance.
How CRISPR Can Be Used to Study GO:2001287 negative regulation of caveolin-mediated endocytosis
Knockout
CRISPR knockout of candidate genes such as PICK1 or CAV1 can test whether loss of function increases caveolin-mediated endocytosis. Knockout models are essential for establishing causality in uptake assays. Parallel knockout of clathrin pathway genes helps confirm specificity.
Point Mutation
Point mutations can disrupt specific domains required for negative regulation, such as caveolin-binding or degradation motifs. These models distinguish loss of a single function from complete protein loss. They are useful for testing disease-associated variants.
Knock-in
Knock-in of tagged or variant alleles allows tracking of endogenous proteins during negative regulation. Tagged knock-in enables imaging and affinity purification without overexpression artifacts. Disease-variant knock-in can reveal altered trafficking.
Overexpression
Overexpression of candidate negative regulators can reduce caveolin-mediated uptake and reveal dose-dependent effects. It is a rapid screening approach before generating knockout models. Combining overexpression with pathway-specific cargo assays confirms specificity.
How EDITGENE Supports negative regulation of caveolin-mediated endocytosis Research
Researchers studying negative regulation of caveolin-mediated endocytosis-related genes often need to determine whether a candidate gene is causally involved in reducing caveolin-dependent uptake, or whether observed effects are secondary to changes in clathrin-mediated trafficking or cell viability. Rigorous causal testing requires precise genetic models that isolate the pathway of interest and appropriate functional readouts.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of caveolin-mediated endocytosis research.
Frequently Asked Questions About negative regulation of caveolin-mediated endocytosis
What is GO:2001287?
GO:2001287 is the Gene Ontology term for negative regulation of caveolin-mediated endocytosis, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of caveolin-mediated endocytosis.
What is caveolin-mediated endocytosis?
Caveolin-mediated endocytosis is a clathrin-independent internalization route that depends on caveolin proteins and is used by pathogens such as mimivirus and Helicobacter pylori outer membrane vesicles.
What genes are involved in negative regulation of caveolin-mediated endocytosis?
Genes such as PICK1 and CAV1 have been linked to caveolin-dependent trafficking and degradation, while DAB2, LRP6, RAB14, and UT-A1 define the contrasting clathrin-dependent pathway.
How is caveolin-mediated endocytosis different from clathrin-mediated endocytosis?
Caveolin-mediated endocytosis is clathrin-independent, whereas clathrin-mediated endocytosis handles cargoes such as LRP6 via Disabled-2 and UT-A1 via Rab14.
Which pathogens use caveolin-mediated endocytosis?
Mimivirus infects macrophages through phagocytosis, and Helicobacter pylori outer membrane vesicles enter host cells via size-dependent mechanisms that can involve caveolin-dependent routes.
What diseases are linked to caveolin-mediated endocytosis?
Infectious diseases and cancer-related signaling are linked to this pathway, including TGF-beta receptor degradation by PICK1 and pathogen entry.
How can I study negative regulation of caveolin-mediated endocytosis?
Use fluorescent cargo uptake assays, pathway-specific inhibitors, CRISPR knockout, and imaging to measure caveolin-dependent internalization and distinguish it from clathrin-dependent uptake.
What cell models are suitable for studying GO:2001287?
Macrophages, intestinal Caco-2 cells, and epithelial cell lines are suitable, depending on whether the question concerns pathogen entry, inflammation, or receptor trafficking.
Does PICK1 regulate caveolin-mediated endocytosis?
PICK1 promotes caveolin-dependent degradation of TGF-beta type I receptor, providing direct evidence for caveolin-dependent trafficking regulation.
What methods measure caveolin-mediated endocytosis specifically?
Fluorescent cargo uptake combined with clathrin pathway inhibitors or genetic perturbation, plus parallel clathrin-dependent cargo assays, helps measure caveolin-mediated endocytosis specifically.
Conclusion
GO:2001287, negative regulation of caveolin-mediated endocytosis, is a biologically important process that controls a clathrin-independent internalization route exploited by pathogens and used for receptor trafficking. Key regulators such as PICK1 and caveolin proteins provide entry points for mechanistic studies, while contrasting clathrin-dependent pathways involving DAB2, LRP6, RAB14, and UT-A1 help define specificity. Understanding this process has implications for infectious disease, cancer signaling, and inflammation. CRISPR-based models and functional assays are essential tools for identifying and validating negative regulators of this pathway.
References
- 1. Yin L et al.. 2022. Characterization of the MicroRNA Profile of Ginger Exosome-like Nanoparticles and Their Anti-Inflammatory Effects in Intestinal Caco-2 Cells.. J Agric Food Chem 70(15):4725-4734 PMID: 35261246
- 2. Ghigo E et al.. 2008. Ameobal pathogen mimivirus infects macrophages through phagocytosis.. PLoS Pathog 4(6):e1000087 PMID: 18551172
- 3. Zhao B et al.. 2012. PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor.. Cell Res 22(10):1467-78 PMID: 22710801
- 4. Jiang Y et al.. 2012. Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin.. EMBO J 31(10):2336-49 PMID: 22491013
- 5. Su H et al.. 2013. Small GTPase Rab14 down-regulates UT-A1 urea transport activity through enhanced clathrin-dependent endocytosis.. FASEB J 27(10):4100-7 PMID: 23796783
- 6. Pu Y et al.. 2008. Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15.. J Virol 82(16):8112-23 PMID: 18550663
- 7. Turner L et al.. 2018. Helicobacter pylori Outer Membrane Vesicle Size Determines Their Mechanisms of Host Cell Entry and Protein Content.. Front Immunol 9:1466 PMID: 30013553
